Caliper Cuts Loss, Revenues Inch Up in Q1 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences today reported first-quarter revenue growth of one percent, as it cut its net loss sharply on lower costs.

The Hopkinton, Mass.-based firm reported total revenues of $28.7 million for the three-month period ended March 31, compared to $28.5 million for the first quarter of 2009. Though its revenues were up only one percent, excluding the effect of divested non-core operations over the past year, Caliper's revenues were up 13 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.